Cardinal Health, Inc. CAH
220.22
(2.40)
(1.08%)
as of 25 Sep
- Market cap
- $51.6B
- P/E
- 30.3×
Follow CAH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Cardinal Health, Inc. (CAH) Current ratio
Cardinal Health, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 0.9×. Over the past ten years it has ranged from 0.9× (fiscal 2026) to 1.3× (fiscal 2017) — the current reading is the lowest in ten years. That is below the Medical Distribution industry median of 1.1× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Annual
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 0.9× | (5.60%) |
| FY2025 | 0.9× | (4.46%) |
| FY2024 | 1.0× | (2.11%) |
| FY2023 | 1.0× | (7.25%) |
| FY2022 | 1.1× | (4.08%) |
| FY2021 | 1.1× | 2.32% |
| FY2020 | 1.1× | 2.87% |
| FY2019 | 1.1× | (0.43%) |
| FY2018 | 1.1× | (19.71%) |
| FY2017 | 1.3× | 19.85% |
Quarterly
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 0.9× | (2.63%) |
| Mar 2026 | 0.9× | 0.09% |
| Dec 2025 | 0.9× | (5.36%) |
| Sep 2025 | 1.0× | 2.34% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.9×
High 1.3×
Ten-year median
1.1×
Current reading's percentile
8
Current ratio against peers
| Company | Current ratio |
|---|---|
| FOCL FocalTherics compare | 1.6× |
| AHG Akso Health Group Sponsored ADR compare | 1.5× |
| HSIC Henry Schein, Inc. compare | 1.3× |
| YI 111, Inc. Sponsored ADR compare | 1.1× |
| COSM Cosmos Health Inc. compare | 1.1× |
| COR Cencora, Inc. compare | 0.9× |
| MCK McKesson Corporation compare | 0.9× |
| CAH Cardinal Health, Inc. | 0.9× |
| ACH Accendra Health, Inc. compare | 0.4× |
| Medical Distribution industry median | 1.1× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on CAH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement